Department of Pediatrics, Kumamoto University Graduate School of Medical Sciences, Kumamoto, Japan.
Division of Pediatrics, Sendai City Hospital, Sendai, Japan.
J Hum Genet. 2013 Dec;58(12):769-74. doi: 10.1038/jhg.2013.97. Epub 2013 Sep 26.
Organic acidemias (OAs) are rare inborn errors of metabolism. The clinical presentations of methylmalonic acidemia (MMA) and propionic acidemia (PA) in Japan have not yet been examined in detail. We aimed to investigate the clinical presentations of OAs in Japan and evaluate current therapies for improving long-term outcomes, especially in MMA and PA cases. Questionnaires were sent to 928 institutions in 2009 inquiring about OAs, and secondary questionnaires were sent to those who confirmed that they had diagnosed and/or treated such cases; 119 cases were eventually included for analysis. In Japan, the majority of OAs was MMA, which was associated with a high mortality rate. The survival rates at 20 years of age in vitamin B12-unresponsive MMA, vitamin B12-responsive MMA and PA patients were 69.8%, 94.4% and 95.8%, respectively. Factors associated with mortality in MMA were failure to thrive, hypoglycemia and pancreatitis. Factors associated with mental retardation in vitamin B12-unresponsive MMA, vitamin B12-responsive MMA, and PA were seizure and liver dysfunction, seizure and failure to thrive, and failure to thrive, respectively. We advocated that avoiding failure to thrive due to too restricted protein diet, hypoglycemia and pancreatitis associated with mortality lead to improve outcome, especially in vitamin B12-unresponsive MMA patients.
有机酸血症(OAs)是罕见的先天性代谢缺陷。日本甲基丙二酸血症(MMA)和丙酸血症(PA)的临床表现尚未详细研究。我们旨在研究日本有机酸血症的临床表现,并评估改善长期预后的当前治疗方法,特别是在 MMA 和 PA 病例中。2009 年,我们向 928 个机构发送了有关 OAs 的调查问卷,并向那些确认诊断和/或治疗此类病例的机构发送了补充调查问卷;最终分析了 119 例病例。在日本,大多数 OAs 是 MMA,其死亡率较高。未经维生素 B12 治疗的 MMA、维生素 B12 反应性 MMA 和 PA 患者在 20 岁时的存活率分别为 69.8%、94.4%和 95.8%。与 MMA 相关的死亡因素有生长不良、低血糖和胰腺炎。与未经维生素 B12 治疗的 MMA、维生素 B12 反应性 MMA 和 PA 相关的智力障碍的因素分别为癫痫和肝功能障碍、癫痫和生长不良以及生长不良。我们主张避免因蛋白质摄入限制导致的生长不良、与死亡率相关的低血糖和胰腺炎,以改善预后,特别是在未经维生素 B12 治疗的 MMA 患者中。